Lin Shaobin signed Share Transfer Agreement to acquire a 8% stake in Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) from Chen Yonghong, Huang Zhiyong and Huang Libing for approximately CNY 410 million on June 9, 2021. Under the transaction, Chen Yonghong will transfer 36,280,599 shares representing 7.15% stake, Huang Zhiyong will transfer 3,612,940 shares representing 0.71% stake, and Huang Libing will transfer 707,248 shares representing 0.14% stake at a price of CNY 10 per share. Post transaction, Chen Yonghong will have 192.60401 million shares representing 3.8% stake in Guangdong Jiaying Pharmaceutical Co., Ltd.
Lin Shaobin signed cancelled the acquisition of 8% stake in Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) from Chen Yonghong, Huang Zhiyong and Huang Libing on November 1, 2021. The shareholders and Lin Shaobin have negotiated and reached an agreement on the termination of the agreement to transfer the company?s shares. The main content of the agreement is as follows: The two parties fully negotiated and agreed to cancel the signed "Chen Yonghong, Huang ZhiYong, Huang Libing and Lin Shaobin on the Share Transfer Agreement of Guangdong Jiaying Pharmaceutical Co., the two parties shall not be liable for each other?s breach of contract, nor shall the parties have any outstanding rights and obligations to each other. This cancellation agreement will become effective as soon as it is signed by both parties. After the termination of the agreement transfer, as of the disclosure date of this announcement, Chen Yonghong holds 50,778,500 shares of the company, accounting for 10.01% of the company?s total share capital; Zhiyong holds 24,997,848 shares of the company, accounting for the total share capital of the company 4.93%; Huang Libing holds 707248 shares of the company, accounting for 0.14% of the company's total share capital.